These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 18852223

  • 1. IgA antiphospholipid antibodies are an independent risk factor for thromboses.
    Shen YM, Lee R, Frenkel E, Sarode R.
    Lupus; 2008 Nov; 17(11):996-1003. PubMed ID: 18852223
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis.
    Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y.
    J Rheumatol; 1998 Sep; 25(9):1730-6. PubMed ID: 9733453
    [Abstract] [Full Text] [Related]

  • 3. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC.
    Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
    [Abstract] [Full Text] [Related]

  • 4. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 5. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance.
    Selva-O'Callaghan A, Ordi-Ros J, Monegal-Ferran F, Martinez N, Cortes-Hernandez F, Vilardell-Tarres M.
    Thromb Haemost; 1998 Feb; 79(2):282-5. PubMed ID: 9493576
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study.
    Ruffatti A, Del Ross T, Ciprian M, Nuzzo M, Rampudda M, Bertero MT, Bergia R, Caramaschi P, Biasi D, Capsoni F, Montaguti L, Ruffini R, Brucato A, Picillo U, Fanelli V, Riccieri V, Piccoli A, Valesini G, Doria A, Meroni PL, Tincani A.
    Ann Rheum Dis; 2009 Mar; 68(3):397-9. PubMed ID: 18812393
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
    Harrison CN, Donohoe S, Carr P, Dave M, Mackie I, Machin SJ.
    Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
    [Abstract] [Full Text] [Related]

  • 12. Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients.
    Brusch A, Bundell C, Hollingsworth P.
    Pathology; 2014 Apr; 46(3):234-9. PubMed ID: 24614715
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke.
    Kahles T, Humpich M, Steinmetz H, Sitzer M, Lindhoff-Last E.
    Rheumatology (Oxford); 2005 Sep; 44(9):1161-5. PubMed ID: 15927998
    [Abstract] [Full Text] [Related]

  • 14. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess.
    Pérez D, Tincani A, Serrano M, Shoenfeld Y, Serrano A.
    Lupus; 2018 Feb; 27(2):177-178. PubMed ID: 29067871
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.
    Sanmarco M, Alessi MC, Harle JR, Sapin C, Aillaud MF, Gentile S, Juhan-Vague I, Weiller PJ.
    Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
    Salobir B, Sabovic M, Hojnik M, Cucnik S, Kveder T.
    Immunobiology; 2007 May; 212(3):193-9. PubMed ID: 17412286
    [Abstract] [Full Text] [Related]

  • 18. Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic.
    Takeishi M, Mimori A, Nakajima K, Mimura T, Suzuki T.
    Clin Rheumatol; 2003 Feb; 22(1):40-4. PubMed ID: 12605317
    [Abstract] [Full Text] [Related]

  • 19. Antiphospholipid and thrombosis syndromes.
    Bick RL, Baker WF.
    Semin Thromb Hemost; 1994 Feb; 20(1):3-15. PubMed ID: 8059232
    [Abstract] [Full Text] [Related]

  • 20. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?
    Galli M.
    J Autoimmun; 2000 Sep; 15(2):101-5. PubMed ID: 10968893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.